# EDGAR Filing Document

**Accession Number:** 0001136869
**File Stem:** 0001193125-26-242207
**Filing Date:** 2026-5
**Character Count:** 8053
**Document Hash:** cb42171206c3463030dca90a0f9d8a4d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-242207.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0001193125-26-242207

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 9

**CONFORMED PERIOD OF REPORT**: 20260522

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ZIMMER BIOMET HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001136869
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 134151777
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16407
- **FILM NUMBER:** 261027684

**BUSINESS ADDRESS:**
- **STREET 1:** 345 EAST MAIN STREET
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46580
- **BUSINESS PHONE:** 5742676131

**MAIL ADDRESS:**
- **STREET 1:** 345 EAST MAIN STREET
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46580

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZIMMER HOLDINGS INC
- **DATE OF NAME CHANGE:** 20010315

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** May 22, 2026<br>

------

ZIMMER BIOMET HOLDINGS, INC.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-16407 | 13-4151777 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 345 East Main Street |  |  |
| Warsaw**,** Indiana |  | 46580 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (574) 373-3333<br>

**Not applicable**<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, $0.01 par value | ZBH | New York Stock Exchange |
| 2.425% Notes due 2026 | ZBH 26 | New York Stock Exchange |
| 1.164% Notes due 2027 | ZBH 27 | New York Stock Exchange |
| 3.518% Notes due 2032 | ZBH 32 | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

Zimmer Biomet Holdings, Inc. (the "Company") held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•elected ten (10) directors for one-year terms ending at the 2027 annual meeting of shareholders (Proposal 1);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•ratified the Audit Committee's appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026 (Proposal 2);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement (Proposal 3); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•rejected a shareholder proposal on Independent Board Chairman (Proposal 4).

The vote tabulation for each proposal follows:

Proposal 1 – Election of Directors

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;<u>Nominee</u> | &nbsp;&nbsp;<u>For</u> | &nbsp;&nbsp;<u>Against</u> | &nbsp;&nbsp;<u>Abstain</u> | &nbsp;&nbsp;<u>Broker Non-Votes</u> |
| &nbsp;&nbsp;Betsy J. Bernard | &nbsp;&nbsp;162573610 | &nbsp;&nbsp;6060594 | &nbsp;&nbsp;92412 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Michael J. Farrell | &nbsp;&nbsp;164446421 | &nbsp;&nbsp;4180484 | &nbsp;&nbsp;99711 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Robert A. Hagemann | &nbsp;&nbsp;162498257 | &nbsp;&nbsp;6126364 | &nbsp;&nbsp;101995 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Arthur J. Higgins | &nbsp;&nbsp;164389482 | &nbsp;&nbsp;4236047 | &nbsp;&nbsp;101087 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Maria Teresa Hilado | &nbsp;&nbsp;163739579 | &nbsp;&nbsp;4797047 | &nbsp;&nbsp;189990 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Syed Jafry | &nbsp;&nbsp;165972307 | &nbsp;&nbsp;2648596 | &nbsp;&nbsp;105713 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Sreelakshmi Kolli | &nbsp;&nbsp;166889697 | &nbsp;&nbsp;1734443 | &nbsp;&nbsp;102476 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Devdatt Kurdikar | &nbsp;&nbsp;160889975 | &nbsp;&nbsp;7634226 | &nbsp;&nbsp;202415 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Louis A. Shapiro | &nbsp;&nbsp;167514405 | &nbsp;&nbsp;1110244 | &nbsp;&nbsp;101967 | &nbsp;&nbsp;12009707 |
| &nbsp;&nbsp;Ivan Tornos | &nbsp;&nbsp;162652958 | &nbsp;&nbsp;5540638 | &nbsp;&nbsp;533020 | &nbsp;&nbsp;12009707 |

---

Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;<u>For</u> | &nbsp;&nbsp;<u>Against</u> | &nbsp;&nbsp;<u>Abstain</u> | &nbsp;&nbsp;<u>Broker Non-Votes</u> |
| &nbsp;&nbsp;172,738,361 | &nbsp;&nbsp;7,887,786 | &nbsp;&nbsp;110,176 | &nbsp;&nbsp;0 |

---

Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;<u>For</u> | &nbsp;&nbsp;<u>Against</u> | &nbsp;&nbsp;<u>Abstain</u> | &nbsp;&nbsp;<u>Broker Non-Votes</u> |
| &nbsp;&nbsp;160,066,066 | &nbsp;&nbsp;8,386,847 | &nbsp;&nbsp;273,703 | &nbsp;&nbsp;12,009,707 |

---

Proposal 4 – Approval of Shareholder Proposal on Independent Board Chair

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;<u>For</u> | &nbsp;&nbsp;<u>Against</u> | &nbsp;&nbsp;<u>Abstain</u> | &nbsp;&nbsp;<u>Broker Non-Votes</u> |
| &nbsp;&nbsp;31,288,886 | &nbsp;&nbsp;137,043,058 | &nbsp;&nbsp;394,672 | &nbsp;&nbsp;12,009,707 |

---

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Exhibits

---

| | |
|:---|:---|
| **EXHIBIT INDEX** | **EXHIBIT INDEX** |
| <u>Exhibit No.</u> | <u>Description</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 27, 2026

---

| | |
|:---|:---|
| ZIMMER BIOMET HOLDINGS, INC. | ZIMMER BIOMET HOLDINGS, INC. |
| By: | /s/ Chad F. Phipps |
| Name: | Chad F. Phipps |
| Title: | Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary |

---

------